FDAnews
www.fdanews.com/articles/108128-aerocrine-to-market-asthma-test-in-china

Aerocrine to Market Asthma Test in China

June 27, 2008

Aerocrine’s hand-held airway inflammation monitor, Niox Mino, has been registered for marketing and sale in China for the treatment of asthma.

Measuring airway inflammation helps optimize treatment for asthma patients.

The company’s method of measuring inflammation, using exhaled nitric oxide tests, has been incorporated into China’s newly revised national guidelines for asthma management, Aerocrine said.